Ian G Webb1, S T Yam2, Russel Cooke3, Andrew Aitken1, Peter D Larsen4, Scott A Harding5. 1. Wellington Cardiovascular Research Group, Wellington, New Zealand; Department of Cardiology, Wellington Hospital, Wellington, New Zealand. 2. University of Otago, Wellington, New Zealand. 3. Laboratory Services, Wellington Hospital, Wellington, New Zealand. 4. Wellington Cardiovascular Research Group, Wellington, New Zealand; University of Otago, Wellington, New Zealand. Electronic address: peter.larsen@otago.ac.nz. 5. Wellington Cardiovascular Research Group, Wellington, New Zealand; Department of Cardiology, Wellington Hospital, Wellington, New Zealand; Victoria University of Wellington, Wellington, New Zealand.
Abstract
AIMS: This study aimed to determine the frequency of baseline high-sensitivity troponin T (hs-TnT) elevation in different age groups presenting to the Emergency Department without acute coronary syndromes (ACS) or other acute illnesses known to cause to troponin elevation. We additionally sought to determine whether the relationship between age and hs-TnT was independent of co-morbidities. METHODS: We retrospectively analysed data on all patients presenting to the Emergency Department (ED) between November 2010 and June 2011 in whom hs-TnT was measured. Patients presenting with acute coronary syndromes (ACS) or other acute illness known to elevate hs-TnT levels were excluded. Demographics, clinical characteristics and diagnosis were recorded, together with hs-TnT assay results. RESULTS: Of 3219 patients with hs-TnT testing in the ED during the study period, 526 with proven/suspected ACS and 1376 with other acute medical conditions known to elevate troponin concentrations were excluded. The percentage of patients with hs-TnT concentrations elevated above the upper reference limit (>14ng/L) increased with age: <50 years (1.8%), 50-69 years (7.3%), ≥70 years (41.5%), p=0.001. Multivariate analysis identified age over 70 years (p<0.001) as the strongest independent predictor of elevated hs-TnT. Other independent predictors included atrial fibrillation (p<0.001), age 50-69 years (p<0.001) male gender (p<0.001), previous heart failure (p<0.007) and previous ischaemic heart disease (p<0.04). CONCLUSIONS: Hs-TnT elevations (>14ng/L) are common in elderly patients presenting to the ED without ACS or other acute illnesses known to cause to troponin elevation. This finding appears to be independent of the higher burden of co-morbidities in this age group.
AIMS: This study aimed to determine the frequency of baseline high-sensitivity troponin T (hs-TnT) elevation in different age groups presenting to the Emergency Department without acute coronary syndromes (ACS) or other acute illnesses known to cause to troponin elevation. We additionally sought to determine whether the relationship between age and hs-TnT was independent of co-morbidities. METHODS: We retrospectively analysed data on all patients presenting to the Emergency Department (ED) between November 2010 and June 2011 in whom hs-TnT was measured. Patients presenting with acute coronary syndromes (ACS) or other acute illness known to elevate hs-TnT levels were excluded. Demographics, clinical characteristics and diagnosis were recorded, together with hs-TnT assay results. RESULTS: Of 3219 patients with hs-TnT testing in the ED during the study period, 526 with proven/suspected ACS and 1376 with other acute medical conditions known to elevate troponin concentrations were excluded. The percentage of patients with hs-TnT concentrations elevated above the upper reference limit (>14ng/L) increased with age: <50 years (1.8%), 50-69 years (7.3%), ≥70 years (41.5%), p=0.001. Multivariate analysis identified age over 70 years (p<0.001) as the strongest independent predictor of elevated hs-TnT. Other independent predictors included atrial fibrillation (p<0.001), age 50-69 years (p<0.001) male gender (p<0.001), previous heart failure (p<0.007) and previous ischaemic heart disease (p<0.04). CONCLUSIONS: Hs-TnT elevations (>14ng/L) are common in elderly patients presenting to the ED without ACS or other acute illnesses known to cause to troponin elevation. This finding appears to be independent of the higher burden of co-morbidities in this age group.
Authors: Saima Hilal; Yuek Ling Chai; Susanne van Veluw; Muhammad Amin Shaik; Mohammad Kamran Ikram; Narayanaswamy Venketasubramanian; Arthur Mark Richards; Geert Jan Biessels; Christopher Chen Journal: JAMA Neurol Date: 2017-04-01 Impact factor: 18.302
Authors: Saima Hilal; Yuek Ling Chai; Mohammad Kamran Ikram; Sakktivel Elangovan; Tan Boon Yeow; Xu Xin; Jun Yi Chong; Narayanaswamy Venketasubramanian; Arthur Mark Richards; Jenny P C Chong; Mitchell Kim Peng Lai; Christopher Chen Journal: Medicine (Baltimore) Date: 2015-01 Impact factor: 1.889
Authors: Nick S R Lan; Damon A Bell; Kieran A McCaul; Samuel D Vasikaran; Bu B Yeap; Paul E Norman; Osvaldo P Almeida; Jonathan Golledge; Graeme J Hankey; Leon Flicker Journal: J Am Heart Assoc Date: 2019-03-05 Impact factor: 5.501
Authors: Anthony Ming-Yu Chuang; Mau T Nguyen; Ehsan Khan; Dylan Jones; Matthew Horsfall; Sam Lehman; Nathaniel R Smilowitz; Kristina Lambrakis; Martin Than; Julian Vaile; Ajay Sinhal; John K French; Derek P Chew Journal: PLoS One Date: 2021-03-12 Impact factor: 3.240